About Joshua Yang
Form D filings for Glyphic Biotechnologies in 2024 list Joshua Yang as chief executive officer and director.
Joshua Yang first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Joshua Yang in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Joshua Yang works with at each company, as listed on that company's latest Form D.
Glyphic Biotechnologies, Inc. · Form D, Feb 16, 2024